Conference Proceedings

Long-Term Safety and Efficacy and Association between Baseline Treatment History and Postbaseline Relapses in Multiple Sclerosis Patients Treated with Natalizumab in the TYSABRI (R) Observational Program (TOP)

Ludwig Kappos, Shibeshih Belachew, Helmut Butzkueven, Fabio Pellegrini, Maria Trojano, Heinz Wiendl, Annie Zhang, Christophe Hotermans

Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2012